Disease Stage and Motor Fluctuation Duration Predict Drug Tolerability: A Real-Life, Prospective Italian Multicenter Study on the Use of Opicapone in Parkinson's Disease

Abstract Background Opicapone is a third-generation catechol-O-methyl-transferase inhibitor currently used for the treatment of motor fluctuations in Parkinson's disease. Its benefit and safety have been established by clinical trials; however, data about its use in a real-life context, and par...

Full description

Saved in:
Bibliographic Details
Main Authors: Ruggero Bacchin (Author), Marco Liccari (Author), Mauro Catalan (Author), Lucia Antonutti (Author), Paolo Manganotti (Author), Maria Chiara Malaguti (Author), Bruno Giometto (Author)
Format: Book
Published: Adis, Springer Healthcare, 2024-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available